Your partner in Europe
  • Print page
  • Bookmark Page


Recordati offers both prescription and OTC products in a wide range of therapeutic areas.

Recordati’s flagship product is ZANIDIP® (lercanidipine), a latest generation calcium-channel blocker for the treatment of hypertension. It is a lipophilic dihydropyridine, discovered and entirely developed by Recordati, with the following characteristics: natural once a day, potent, long-lasting vasodilatory activity, highly vasoselective with gradual onset, smooth and uniform blood pressure lowering activity and improved tolerability over other dihydropyridines.

We offer a wide range of innovative pharmaceuticals in specific therapeutic areas:

  • Antibiotics and Antivirals
  • Cardiovascular
  • Central nervous system
  • Dermatological
  • Gastroenterology
  • Genito-urinary system
  • Muscolo-skeletal disorders and pain therapy
  • Obstetics and Gynaecology
  • OTC (non-prescription pharmaceuticals)


Our Markets

Last updated on:
05:13:54 CET
Delivered by Investis (opens in a new window)